The new time-saving test is intended for people with MGUS (Monoclonal Gammopathy of Unknown Significance), a precursor condition of myeloma.

OSU scientists created nanoparticles that deliver anti-inflammatory drugs across the blood-brain barrier, offering hope for ...

In a landmark shift, the US Food and Drug Administration (FDA) has announced a transformative initiative to advance public health by replacing animal testing in drug development—including monoclonal ...

Roche's strong U.S. presence and diversified product portfolio may mitigate the impact of potential tariffs, making it a ...

The FDA will begin replacing animal testing in the development of monoclonal antibody therapies and other drugs with ...

On Thursday, shares in Charles River Laboratories, a leading contract research organizations that has stirred controversy over its use of non-human primates, plunged 28 percent after the FDA issued ...

Recursion Pharmaceuticals' stock is soaring today on news the FDA is planning on phasing out some animal testing, replacing ...

The FDA announced a shift away from animal testing for drug approval, citing advanced alternatives like AI and organoids ...

It’s unclear whether tariffs will influence more companies to make more drugs in the U.S. like President Donald Trump is hoping for, some experts said.

Researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening the door to potential new therapies for a range of conditions, including Alzheimer's disease ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...